By targeting the tumor-specific macrophages using C5aRA with MEKi, it may be possible to minimize the autoimmune complications of ICIs; C5a up-regulation in PNF is local, so its targeting of macrophages may not induce systemic autoimmune toxicity. The gene discussed is C5; the disease is neoplasm.